No abstract available
Keywords:
PSCK9 inhibitor; atherosclerosis; bempedoic acid; coronary artery bypass grafting; coronary artery disease; ezetimibe; inclisiran; statin intolerance; statin-associated muscle symptoms.
MeSH terms
-
Anticholesteremic Agents*
-
Cholesterol, LDL
-
Coronary Artery Bypass / adverse effects
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
-
Hypercholesterolemia*
Substances
-
Cholesterol, LDL
-
Anticholesteremic Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors